 |
Previous Article | Next Article 
The Journal of Neuroscience, February 1, 2002, 22(3):666-673
Functional Specificity of G q and
G 11 in the Cholinergic and Glutamatergic Modulation of
Potassium Currents and Excitability in Hippocampal Neurons
Michael
Krause1,
Stefan
Offermanns2,
Martin
Stocker1, 3, and
Paola
Pedarzani1, 4
1 Max-Planck-Institute for Experimental Medicine,
Department of Molecular Biology of Neuronal Signals, 37075 Göttingen, Germany, 2 Institute of Pharmacology,
University of Heidelberg, 69120 Heidelberg, Germany, and
3 Wellcome Laboratory for Molecular Pharmacology,
Department of Pharmacology, and 4 Department of Physiology,
University College London, London WC1E 6BT, United Kingdom
 |
ABSTRACT |
In hippocampal and other cortical neurons, action potentials are
followed by a slow afterhyperpolarization (sAHP) generated by the
activation of small-conductance Ca2+-activated
K+ channels and controlling spike frequency
adaptation. The corresponding current, the apamin-insensitive
sIAHP, is a well known target of
modulation by different neurotransmitters, including acetylcholine (via
M3 receptors) and glutamate (via metabotropic glutamate
receptor 5, mGluR5), in CA1 pyramidal neurons. The
actions of muscarinic and mGluR agonists on
sIAHP involve the activation of pertussis toxin-insensitive G-proteins. However, the pharmacological tools available so far did not permit the identification of the specific G-protein subtypes transducing the effects of M3 and
mGluR5 on sIAHP. In the present
study, we used mice deficient in the G q and
G 11 genes to investigate the specific role of these
G-protein subunits in the cholinergic and glutamatergic modulation
of sIAHP in CA1 neurons. In mice lacking
G q, the effects of muscarinic and glutamatergic
agonists on sIAHP were nearly abolished,
whereas -adrenergic agonists acting via G s were still
fully effective. Modulation of sIAHP by any
of these agonists was instead unchanged in mice lacking
G 11. The additional depolarizing effects of muscarinic and glutamatergic agonists on CA1 neurons were preserved in mice lacking G q or G 11. Thus,
G q, but not G 11, mediates
specifically the action of cholinergic and glutamatergic agonists on
sIAHP, without affecting the
modulation of other currents. These results provide to our knowledge
one of the first examples of the functional specificity of
G q and G 11 in central neurons.
Key words:
G-protein; muscarinic; metabotropic glutamate; calcium-activated potassium current; afterhyperpolarization; CA1
pyramidal neurons
 |
INTRODUCTION |
In the hippocampus, glutamatergic
and cholinergic regulation of neuronal excitability is thought to play
a pivotal role in learning and memory processes (Pin and Bockaert,
1995 ; Riedel, 1996 ; Segal and Auerbach, 1997 ; Holscher et al., 1999 ;
Perry et al., 1999 ). Acetylcholine and glutamate, beside mediating fast excitatory synaptic transmission in the CNS, modulate neuronal metabolic responses by acting on metabotropic receptors (muscarinic and
metabotropic glutamate receptors, mGluRs). Previous studies have
focussed on the molecular and cellular mechanisms by which muscarinic
and mGluR agonists regulate membrane excitability in central and
peripheral neurons and have revealed their effects on several ionic
currents, such as the following: (1) the M current (IM), a voltage-dependent
K+ current (Brown and Adams, 1980 ;
Halliwell and Adams, 1982 ); (2) a voltage-independent "leak"
K+ current
[IK(leak)] (Madison et al., 1987 ;
McCormick and von Krosigk, 1992 ; Guerineau et al., 1994 ); (3) the
slowly inactivating K+ current
ID (Wu and Barish, 1999 ); (4) the
delayed rectifier K+ current
IK (Zhang et al., 1992 ); (5) the
unspecific cationic pacemaker current
(Ih) (Colino and Halliwell, 1993 ); (6)
a Ca2+-dependent, cation-nonspecific
current (Crepel et al., 1994 ; Greene et al., 1994 ; Guerineau et al.,
1995 ; Haj-Dahmane and Andrade, 1997 , 1999 ); and (7) the
Ca2+-activated
K+ current responsible for the slow
afterhyperpolarization (sIAHP) (Benardo and Prince, 1982 ; Cole and Nicoll, 1983 , 1984 ; Charpak et al.,
1990 ).
The signal transduction pathways mediating these muscarinic and mGluR
effects are only partly understood in hippocampal as in other central
neurons. In particular, the involvement and molecular identification of
G-proteins has been carefully investigated in some peripheral (Hille,
1994 ; Brown et al., 1997 ), but not in central neurons. Pertussis
toxin-insensitive G-proteins have been proposed to be involved in the
suppression of IM,
sIAHP, and
IK(leak) by muscarinic agonists in CA1
neurons (Dutar and Nicoll, 1988 ). However, the lack of selective
pharmacological tools and the difficulty of successfully applying
antisense or antibody techniques, as in dissociated or cultured cells
(McFadzean et al., 1994 ; Ikeda, 1997 ; Buckley et al., 2000 ), has so far
prevented the identification of specific G-protein subtypes mediating
cholinergic and glutamatergic actions in central neurons in
situ. Their identification is important, because the diversity of
G-protein forms is likely to be matched by a corresponding range of
cellular targets and functions.
The high structural homology, overlapping distribution patterns, and
similar coupling properties to downstream effectors of G q and G 11 subunits
(Wu et al., 1992 ; Offermanns et al., 1994 ; Exton, 1996 ; Offermanns,
1999 ) have raised the question of their functional specificity in
physiological systems. In this study, we unequivocally identified the
G-protein subtypes that selectively transduce the signals of muscarinic
M3 and glutamatergic mGluR5 receptors on sIAHP in CA1 pyramidal
neurons in mouse hippocampal slices. Using knock-out mice lacking
G q or G 11 subunits,
we showed that G q, but not
G 11, mediates the downregulation of sIAHP by both muscarinic and mGluR
agonists. Neither G q nor
G 11 seem instead to be required for the slow
depolarization induced by these agonists. This study provides, to our
knowledge, the first evidence of precise and distinct roles of these
two G-protein subunit isoforms in physiologically relevant
signaling pathways in central neurons.
 |
MATERIALS AND METHODS |
G q- and
G 11-deficient mice. Mice deficient in
the G q gene (G q
/ ) or the G 11 gene
(G 11 / ) were generated by targeted disruption with a neomycin gene as described previously (Offermanns et
al., 1997 , 1998 ). G q / and
G 11 / mice used in the experiments were
obtained by mating heterozygous males and females to obtain wild-type
(G q +/+; G 11 +/+) and
knock-out (G q / ;
G 11 / ) littermates. Mice were kept on a
C57BL/6 × 129/Sv background, and genotypes were confirmed by
PCR on genomic DNA from tail biopsies of each mouse. All experiments
were performed in a double-blind manner, and the code was broken only
after completion of the experimental work and data analysis.
Slice preparation. Acute slices were obtained from Wistar
rats (18-28 d old), G q / mice (11-24
weeks old), G 11 / mice (14-25 weeks old),
or wild-type mice. Wild-type mice were NMRI albino mice (4-8 weeks
old), C57BL/6J (8-12 weeks old) mice, or littermates of
G q / or G 11 /
(11-25 weeks old). Throughout the text, it is specified to which group
we refer according to the experiment performed. Transversal hippocampal
slices (300-400 µm) were cut with either a tissue chopper (Mickle
Laboratory, Gomshall, Surrey, UK) or a vibratome (Leica,
Nussloch, Germany) and subsequently incubated in a humidified
interface chamber at room temperature for 1 hr.
Electrophysiology. Tight-seal whole-cell voltage-clamp
recordings were obtained using the "blind method" (Blanton et al., 1989 ). Patch electrodes (4-7 M ) were filled with an intracellular solution containing (in mM): 140 potassium
methylsulfate, 10 HEPES, 2 Na2-ATP, 0.4 Na3-GTP, and 3 MgCl2
(osmolarity, 280-300 mOsm), pH 7.2-7.3 with KOH. Recordings were
performed in a submerged recording chamber with a constant flow of
artificial CSF (ACSF) (2 ml/min) at room temperature
(22-24°C). Drugs were applied in the bath solution. ACSF contained
(in mM): 125 NaCl, 1.25 KCl, 2.5 CaCl2, 1.5 MgCl2, 1.25 KH2PO4, 25 NaHCO3, and 16 D-glucose [bubbled with carbogen (95% O2-5%
CO2]. In all recordings, tetrodotoxin (TTX) (0.5 µM), tetraethylammonium (TEA) (5 mM), and picrotoxin (5 µM) were added to the superfusing ACSF.
Whole-cell patch-clamp recordings were obtained from 90 neurons from
mice and 13 from rats in acute hippocampal slices. Neurons were voltage
clamped at 60 mV, and 100- to 200-msec-long depolarizing pulses to
0-30 mV were delivered every 30 sec. These pulses led to unclamped Ca2+ action currents sufficient to
activate AHP currents. Slow depolarizing currents were measured as
changes in the holding current under the same experimental conditions
(same intracellular and extracellular solutions; holding potential of
60 mV). Series resistance was regularly monitored, and only
recordings with stable series resistances 35 M were included in
this study. No series resistance compensation and no corrections for
liquid junction potentials were made. Data were acquired using a
patch-clamp EPC9 amplifier (Heka Elektronik, Lambrecht/Pfalz, Germany),
filtered with a 3 dB cutoff frequency at 250 Hz, sampled at 1 KHz,
and stored on a Macintosh Power personal computer (Apple Computers,
Cupertino, CA). Analysis was made using the programs Pulse and Pulsefit
(Heka), Igor Pro 3.01 (WaveMetrics Inc., Lake Oswego, OR), and Excel
(Microsoft, Seattle, WA). We analyzed the amplitude, charge transfer
(area enclosed by IAHP and
sIAHP), and time course of AHP
currents decay. No discrepancies in the variations of these parameters
on pharmacological manipulations were observed; therefore, in Results
and the figures, we reported only the values concerning
IAHP and
sIAHP amplitudes. The amplitude of
IAHP was determined at the peak of the
current, whereas that of sIAHP was
determined at a point 700-800 msec after the end of the command pulse,
in which a possible contamination by the partially overlapping
IAHP was negligible (Stocker et
al., 1999 ). Values are presented as mean ± SEM. For statistical
analysis, the unpaired, two-tailed Student's t test was
used, and differences were considered statistically significant if
p 0.05.
Drugs and solutions. TEA, carbamylcholine (carbachol, CCh),
Na2-ATP, and Na3-GTP were
obtained from Sigma (St. Louis, MO). TTX was from Alomone Labs
(Jerusalem, Israel). Picrotoxin and isoproterenol were from Research
Biochemicals (Natick, MA).
trans-1-Amino-cyclopentyl-1,3-dicarboxylate (trans-ACPD) and
(S)-3,5-dihydroxyphenyl-glycine (DHPG) were from Tocris Cookson (Bristol, UK). All drugs were dissolved in water, stored
at +4°C or 20°C, and bath applied in the perfusing ACSF.
 |
RESULTS |
AHP currents in the mouse hippocampus
Rat CA1 pyramidal neurons have been shown to present two distinct
Ca2+-dependent afterhyperpolarizing
currents, contributing to the early and late spike frequency
adaptation: IAHP, deactivating in
hundreds of milliseconds and sensitive to the toxin apamin; and
sIAHP, characterized by a slow
deactivation (in the range of seconds), insensitive to apamin and
sensitive to the neuromodulatory effects of a number of transmitters
(Stocker et al., 1999 ). In mouse hippocampal pyramidal neurons, the
types of AHP currents and their key features are still unexplored. In
CA1 pyramidal neurons from mouse slices, short depolarizing pulses
inducing Ca2+ influx elicited an
apamin-sensitive IAHP in 94.9% of the
cells, followed by an apamin-insensitive
sIAHP in 77.8% (Fig.
1A). In two different
strains of wild-type mice tested, NMRI and C57BL/6, sIAHP presented an amplitude of
19.6 ± 3.5 (n = 11) and 25.6 ± 3.4 (n = 31) pA, respectively, whereas in Wistar rats, the
sIAHP amplitude was substantially
larger (109.8 ± 13.5 pA; n = 13) under the same
experimental conditions. The time courses of decay of the two AHP
currents were clearly different: the apamin-sensitive IAHP presented an average decay time
constant of 88.3 ± 4.9 msec, and the apamin-insensitive
sIAHP presented an average decay time constant of 3.5 ± 0.2 sec. In most cells measured,
IAHP coexisted and partially
overlapped with the rising phase of
sIAHP, as shown in Figure
1A (left panel). The
pharmacological separation by apamin (Fig. 1A)
suggests that IAHP and
sIAHP are distinct currents, as
reported previously in rat CA1 pyramidal neurons (Stocker et al.,
1999 ). In all CA1 pyramidal neurons from mouse, as in rat, the
Ca2+ spikes and
sIAHP remained stable for the duration
of the recording (usually ~2-3 hr). Additionally,
sIAHP displayed a normal sensitivity to a number of neurotransmitters (see below), as observed previously in
rat neurons.

View larger version (68K):
[in this window]
[in a new window]
|
Figure 1.
A, Mouse CA1 pyramidal neurons
present a Ca2+-activated, apamin-sensitive
afterhyperpolarizing current (IAHP)
that deactivates in the hundreds of milliseconds range, followed by a
Ca2+-activated, apamin-insensitive AHP current
(sIAHP), lasting seconds.
IAHP is partially overlapping with the rise
time of sIAHP. These currents were elicited
by Ca2+ influx induced by a 100 msec depolarizing
pulse to +10 mV. Traces shown were recorded from CA1 neurons of a
G 11 / mouse. G 11 +/+ littermates, as
well as G q +/+ and G q / mice,
displayed similar currents (see Results). In the right
panel, IAHP was blocked by 50 nM apamin, leaving sIAHP
amplitude and kinetics unaffected. B, Nissl stains of
the hippocampal formation from G q +/+ and
G q / mice. No changes in the gross morphology of the
hippocampus were observed in the knock-out animals when compared with
their wild-type littermates.
|
|
Cholinergic and glutamatergic modulation of
sIAHP is inhibited in
G q-deficient mice
Activation of muscarinic (M3; Rouse et al.,
2000 ; M. Krause and P. Pedarzani, unpublished observation) or
metabotropic (mGluR5; Gereau and Conn, 1995 )
glutamate receptors leads to the suppression of the apamin-insensitive
sIAHP in CA1 pyramidal neurons. The actions of both muscarinic and mGluR agonists on
sIAHP have been shown to involve
activation of G-proteins of the pertussis toxin-insensitive type (Dutar
and Nicoll, 1988 ; Gerber et al., 1992 ; Abdul-Ghani et al., 1996a ;
Krause and Pedarzani, 2000 ). However, pertussis toxin and GDP- -S
used in those studies blocked a wide subset or all G-proteins,
respectively. Therefore, this approach did not allow the identification
of specific G-protein subtypes transducing the effects of
M3 muscarinic and mGluR5
receptor stimulation on sIAHP. We used
mice deficient in the G q gene
(G q / ) to investigate the specific role of
this G-protein in the cholinergic and glutamatergic modulation of
sIAHP. The hippocampus of
G q-deficient mice presented an overall
structure and gross morphology indistinguishable from those of
wild-type animals (Fig. 1B). Additionally,
sIAHP amplitude, time course, and
passive membrane properties (resting membrane potential,
Vm; input resistance,
Ri) were not significantly different in G q /
(Vm of 71.0 ± 1.4 mV;
Ri of 186 ± 9 M ) when
compared with G q +/+ mice
(Vm of 72.4 ± 1.2 mV;
Ri of 190 ± 11 M ) or mice of
a different strain (NMRI; Vm of 68.3 ± 1.8 mV; Ri of 173 ± 13 M ).
The only observed difference was an intrinsically smaller amplitude of
the apamin-sensitive IAHP in the
absence of neuromodulatory agents in G q /
mice (87.6 ± 15.9 pA in G q +/+,
n = 25; 44.1 ± 5.0 pA in
G q / , n = 19;
p = 0.01).
In wild-type mice, the cholinergic agonist carbachol (5 µM) (Fig.
2A,E)
and the mGluR agonists DHPG (2-3 µM) (Fig.
3A,E)
and trans-ACPD (10-20 µM; data not
shown) all produced a robust inhibition of
sIAHP but did not significantly affect
the apamin-sensitive IAHP. In mice
lacking G q, the effects of carbachol and DHPG
on sIAHP were strongly reduced (Fig.
2C,E for CCh; Fig.
3C,E for DHPG), arguing in favor of a
substantial contribution of G q in mediating
the suppression of sIAHP. The apparent
small decrease in IAHP amplitude,
observed in wild-type as in knock-out G q mice during application of these neuromodulatory agents, was most likely attributable to the partial overlap between
IAHP and
sIAHP and the concomitant suppression
of sIAHP (Stocker et al., 1999 ).

View larger version (29K):
[in this window]
[in a new window]
|
Figure 2.
A, In G q +/+ mice, the cholinergic
agonist carbachol (5 µM) strongly and reversibly
suppressed sIAHP. B,
Voltage-clamp recording of the inward current underlying the
depolarizing response to carbachol (5 µM) in CA1 neurons from
G q +/+ mice. The vertical lines
correspond to depolarizing pulses used to elicit the AHP currents once
every 30 sec. The dotted line represents the baseline
holding current before the application of carbachol. The carbachol
application lasted 7 min (solid bar). C,
In G q / mice, 5 µM carbachol induced a
significantly smaller inhibition of sIAHP
than in A. In A and C, the
rightmost panels show superimpositions of the
traces before and during carbachol application.
D, Inward current underlying the depolarizing response
to carbachol (5 µM) in CA1 neurons from G q
/ mice. The carbachol application lasted 7.5 min (solid
bar). All of the rest are as in B.
E, Summary of the results obtained with carbachol in CA1
pyramidal neurons from G q +/+ and G q
/ mice. In G q +/+, carbachol suppressed
sIAHP by 84.0 ± 4.2%
(n = 17), whereas in G q / ,
42.6 ± 5.6% of sIAHP was inhibited
during carbachol application (n = 19). *represents
a statistically significant difference (p < 0.001). In
the same pools of CA1 neurons, carbachol did not significantly
downregulate IAHP in G q +/+
mice (31.8 ± 5.9% inhibition) compared with G q
/ mice (25.5 ± 5.5% inhibition; n = 16;
p = 0.44). F, Scatter plot
summarizing the effect of 5 µM carbachol on the membrane
potential of CA1 pyramidal neurons from G q +/+
(filled circles) and G q /
(filled diamonds) animals. Carbachol elicited a
mean inward shift in the holding current of 14.6 ± 2.0 pA in
G q +/+ (open circle;
n = 13) and 10.3 ± 1.4 pA in
G q / mice (open diamond;
n = 14; p = 0.10).
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Figure 3.
A, The group I mGluR receptor agonist DHPG (3 µM) suppressed sIAHP in a
reversible manner in G q +/+ mice. B,
Inward shift in the holding current underlying the depolarizing
response to DHPG (3 µM) in CA1 neurons from
G q +/+ mice. The vertical lines
correspond to depolarizing pulses used to elicit the AHP currents once
every 30 sec. The dotted line represents the baseline
holding current before the application of DHPG. The DHPG application
lasted 5 min (solid bar). C, In
G q / mice, 3 µM DHPG produced a
significantly smaller inhibition of sIAHP.
In A and C, the rightmost
panels show superimpositions of the traces
before and during DHPG application. D, Depolarizing
current elicited in response to DHPG (3 µM) in CA1
neurons from G q / mice. The DHPG application lasted
7 min (solid bar). All of the rest are as in
B. E, Bar diagram summarizing the results
obtained with DHPG in CA1 pyramidal neurons from G q +/+
and G q / . In G q +/+, 86.9 ± 4.4% of sIAHP was inhibited after DHPG
application (n = 15), whereas in G q
/ , DHPG suppressed sIAHP by 54.7 ± 7.3% (n = 14). *represents a statistically
significant difference (p = 0.001). In the same pools of
CA1 neurons, the small inhibitory effect of DHPG on
IAHP was similar in G q
+/+ (35.9 ± 7.4% inhibition; n = 15) and
G q / (32.5 ± 6.2% inhibition;
n = 12; p = 0.73) mice.
F, Summary of the effect of DHPG (2-3 µM)
on the holding current in G q +/+ (filled
circles) and G q / (filled
diamonds) neurons. DHPG elicited a mean inward depolarizing
current of 15.2 ± 2.0 pA in G q +/+ (open
circle; n = 8) and 11.8 ± 2.7 pA in
G q / (open diamond;
n = 4; p = 0.33).
|
|
Beside downregulating sIAHP,
activation of M3 receptors and
mGluR5 leads to the generation of a depolarizing
inward current in CA1 pyramidal neurons (Figs. 2B,
3B) (Pitler and Alger, 1990 ; Gereau and Conn, 1995 ). The
signal transduction pathway leading to this depolarizing effect is only
partly known. We tested whether G q was
mediating the generation of the depolarizing current during application
of muscarinic and mGluR agonists. The inward current elicited by
carbachol and DHPG was not significantly different in
G q knock-out mice (Fig.
2D,F for CCh; Fig.
3D,F for DHPG) when compared with
their wild-type littermates (Fig.
2B,F for CCh; Fig.
3B,F for DHPG). These results
suggest that G q is not required for the
muscarinic- or mGluR-induced depolarizing inward current in CA1 neurons.
G 11 is not required for the modulation of
sIAHP by muscarinic and mGluR agonists
The remaining effect of muscarinic and mGluR agonists on
sIAHP in
G q-deficient mice might be attributable to
activation of G 11, because this G subunit
is also expressed, although to a lower level, in CA1 pyramidal neurons
(Mailleux et al., 1992 ; Milligan, 1993 ; Tanaka et al., 2000 ) and
displays a similar functional role as G q in
other systems (Wu et al., 1992 ; Offermanns et al., 1994 ; Exton, 1996 ;
Offermanns, 1999 ). To investigate the role of
G 11 in the cholinergic and metabotropic signal
transduction cascades suppressing
sIAHP, we recorded from CA1 neurons of
mice lacking G 11 (G 11
/ ). As in the case of the G q knock-outs, mice lacking G 11 presented a normal
hippocampal gross morphology and intrinsic neuronal properties
indistinguishable from those of control mice (data not shown). In
G 11 / mice and in their wild-type
littermates (G 11 +/+), carbachol (Fig.
4A,C)
and DHPG (Fig. 4B,D) suppressed
sIAHP to the same extent. In the same
neurons, the apamin-sensitive IAHP was
only marginally affected by application of muscarinic (Fig.
4C) and mGluR (Fig. 4D) agonists. These
results demonstrate that G 11 is not required
to transduce the cholinergic and glutamatergic signals that result in
the downregulation of sIAHP.
Therefore, it is unlikely that G 11 is part of
the signal cascade regulating the residual
sIAHP present in
G q / after cholinergic and glutamatergic
receptor activation. In mice lacking G 11, the
depolarizing effects of carbachol and DHPG were indistinguishable from
those observed in their wild-type littermates (data not shown), suggesting that G 11 is not mediating the
muscarinic- or mGluR-induced depolarizing inward current in CA1
neurons.

View larger version (27K):
[in this window]
[in a new window]
|
Figure 4.
A, Left, In
G 11 +/+ mice, 5 µM carbachol strongly
suppressed sIAHP. Right, In
G 11 / , 5 µM carbachol inhibited
sIAHP to the same extent as observed in
G 11 +/+ mice. B, Left,
DHPG (3 µM) induced a robust suppression of
sIAHP in G 11 +/+ mice.
Right, Similarly, in G 11 / , 3 µM DHPG produced a strong inhibition of
sIAHP. In A and
B, traces before and during carbachol and
DHPG applications are shown superimposed. C, Bar diagram
summarizing the results obtained with carbachol in CA1 pyramidal
neurons from G 11 +/+ and G 11 / mice.
In G 11 +/+, carbachol suppressed
sIAHP by 56.2 ± 9.8%
(n = 5), and in G 11, / ,
67.3 ± 7.2% of sIAHP was inhibited
during carbachol application (n = 11). The
difference observed between G 11 +/+ and
G 11 / mice was not statistically significant
(p = 0.39). In the same pools of CA1
neurons, carbachol did not significantly affect
IAHP in G 11 +/+ compared with
G 11 / mice (n = 5 and
n = 10, respectively). D, Bar
diagram summarizing the results obtained with DHPG in CA1 pyramidal
neurons from G 11 +/+ and G 11 / mice.
In G 11 +/+, 60.5 ± 14.2% of
sIAHP was inhibited during DHPG application
(n = 4), and in G 11 / , DHPG
suppressed sIAHP by 68.0 ± 9.6%
(n = 9). The difference observed between
G 11 +/+ and G 11 / mice was not
statistically significant (p = 0.68). In the
same pools of CA1 neurons, DHPG did not significantly affect
IAHP in G 11 +/+ compared with
G 11 / mice (n = 4 and
n = 9, respectively).
|
|
The -adrenergic modulation of sIAHP
is intact in G q-deficient mice
Next, we wanted to test whether the reduction of the effects of
cholinergic and glutamatergic agonists on
sIAHP observed in G q-deficient mice is specific or whether
supposedly unrelated modulatory pathways converging on
sIAHP might be unspecifically affected
in these genetically modified animals. To this purpose, we took
advantage of the fact that sIAHP is
strongly suppressed by monoamine transmitters (noradrenaline,
serotonin, histamine, and dopamine) in rat CA1 pyramidal neurons
(Nicoll, 1988 ; Pedarzani and Storm, 1993 ; Pedarzani and Storm, 1995 ).
Among these transmitters, noradrenaline activates -adrenergic
receptors, which are coupled to G s-subunits
and lead to the stimulation of adenylyl cyclase, increase of cAMP
level, and activation of PKA, finally resulting in a complete
suppression of sIAHP. We used the
-adrenergic agonist isoproterenol, which suppressed
sIAHP both in wild-type (Fig. 5A,C)
and G q-deficient (Fig.
5B,C) mice in an indistinguishable manner but had no significant effect on the apamin-sensitive
IAHP (Fig. 5C). We can
therefore conclude that the absence of G q
impairs specifically cholinergic and glutamatergic signal cascades
suppressing sIAHP, but it does not
affect the modulation of this current by other neurotransmitters
coupled to different second-messenger pathways.

View larger version (25K):
[in this window]
[in a new window]
|
Figure 5.
A, In G q +/+, the
-adrenergic agonist isoproterenol (1 µM) strongly
suppressed sIAHP. B, In
G q / , 1 µM isoproterenol suppressed
sIAHP to a similar extent as in
A. In A and B, the
rightmost panels show superimpositions of the
traces before and during isoproterenol application.
C, Summary of the results obtained with isoproterenol in
CA1 pyramidal neurons from G q +/+ and G q
/ mice. In G q +/+, isoproterenol suppressed
sIAHP by 75.0 ± 11.4%
(n = 6), and in G q / , 83.6 ± 7.8% of sIAHP was inhibited during
isoproterenol application (n = 10). The difference
observed between G q +/+ and G q / mice
was not statistically significant (p = 0.54). In the same pools of CA1 neurons, isoproterenol did not affect
IAHP in G q +/+ differently
from G q / mice (n = 5 and
n = 9, respectively).
|
|
 |
DISCUSSION |
This study presents the first demonstration and characterization
of apamin-sensitive and -insensitive AHP currents in the mouse
hippocampus. Based on this, knock-out animals could be used to analyze
specific transducing elements of signal cascades regulating sIAHP. The primary purpose of the
present experiments was to elucidate which heterotrimeric G-proteins
transduce muscarinic- and mGluR-mediated signals leading to a
downregulation of sIAHP and to an
enhanced excitability of hippocampal pyramidal neurons. To this
purpose, we used mice lacking the G q or
G 11 gene. These mice did not present gross
morphological abnormalities of the CNS and displayed an overall normal
hippocampal morphology. In addition, intrinsic membrane properties
(this study) and basic parameters of synaptic function (input-output
curves and paired-pulse facilitation; Kleppisch et al., 2001 ) were not
altered in the CA1 region. Our results demonstrate that
G q is the main transducing element in these signal cascades leading to sIAHP
suppression, whereas G 11 does not seem to be
required. Neither G q nor
G 11 seem to be involved in mediating the
membrane potential depolarization caused by muscarinic and mGluR
agonists in CA1 pyramidal neurons.
Muscarinic and mGluR downregulation of
sIAHP requires
G q, because the effects of muscarinic and
mGluR agonists were strongly reduced in neurons from
G q knock-out mice. It is unlikely that this
was a result of generalized secondary effects on transduction mechanisms arising from the absence of G q
during development, because muscarinic and mGluR agonists were still
able to elicit the inward, depolarizing current. Furthermore,
transmitters acting via other G-proteins, such as the -adrenergic
agonist isoproterenol acting via G s, fully
suppressed sIAHP in
G q-deficient neurons, indicating a preserved
function of other signaling pathways targeting the same current.
In the absence of G q, muscarinic and mGluR
agonists partially suppressed sIAHP
(Figs. 2, 3). Our first assumption was that this could be attributable
to the presence of G 11, which is expressed at
lower levels in hippocampal neurons (Mailleux et al., 1992 ; Milligan,
1993 ; Tanaka et al., 2000 ) and presents receptor- and effector-coupling
properties very similar to G q (Wu et al.,
1992 ; Offermanns et al., 1994 ; Exton, 1996 ; Offermanns, 1999 ). However, the results we obtained in G 11 knock-out mice
revealed that G 11 is not required for
sIAHP modulation and is therefore
unlikely to substitute for G q in
G q knock-out mice. This observation is further
supported by the lack of compensatory overexpression of
G 11 in the hippocampus of
G q knock-out mice, as shown recently by
immunoblot experiments (Kleppisch et al., 2001 ). Despite this evidence,
in principle the possibility remains that G 11
mediates the residual effect of muscarinic and glutamatergic agonists
observed in G q knock-out mice. This could
happen, for example, if G 11 contributed in a
small but significant way to the muscarinic or glutamatergic action,
resulting in an invisible phenotype in the G 11
knock-out mice but emerging as a sufficient contribution in the
G q knock-outs. A subtle, partial effect linked
to G 11, unmasked in
G q knock-out mice, would be expected to be
slower when compared with the G q-mediated
effect observed in their wild-type littermates, given the lower density
of the G 11 subtype in CA1 pyramidal neurons
(Mailleux et al., 1992 ; Milligan, 1993 ; Tanaka et al., 2000 ). Indeed, a
compensatory phenomenon with altered (slower) kinetics has been
reported recently for the modulation of potassium and calcium channels
by GABAB and adenosine receptors in hippocampal
neurons from mice lacking G o (Greif et al.,
2000 ). This seems unlikely to occur in our case, because the time
course of the residual muscarinic and glutamatergic effects on
sIAHP was not different in
G q knock-out mice when compared with their wild-type littermates [compare Figs.
2B,D (for carbachol,
3B,D (for DHPG)]. However, the
possibility of a marginal G 11 involvement could be conclusively ruled out only by using animal models lacking both G q and G 11
subunits, but unfortunately a double mutant generated by conventional
gene targeting is not viable (Offermanns et al., 1998 ). If conditional
double mutants prove to be viable, they could provide a potential
future approach to unequivocally answer this question.
In several mammalian cells, receptors activating
Gq family members do not seem to discriminate
between G q and G 11
(Wange et al., 1991 ; Wu et al., 1992 ; Offermanns et al., 1994 ), and, in
reconstituted systems, both G-proteins are indistinguishable in their
ability to regulate different phospholipase C (PLC) isoforms (Exton,
1996 ) and inward rectifier potassium channels (Lei et al., 2001 ). In
the light of such apparent functional redundancy, the prominent
involvement of G q and the lack of effect of
G 11 in mediating the cholinergic and
glutamatergic suppression of sIAHP
provide therefore a remarkable indication of functional specificity for
members of the Gq family in the CNS. In line with this view, G q, but not
G 11, has been shown recently to be critically involved in the induction of mGluR-dependent long-term depression in
CA1 pyramidal neurons (Kleppisch et al., 2001 ).
The picture emerging from the results presented here is different from
that which has been observed for another potassium current, the
voltage-dependent IM, in the
peripheral nervous system. In rat superior cervical ganglion neurons,
M1 muscarinic receptors inhibit
IM primarily via
G q (Haley et al., 1998 ). In mouse, inhibition is also mediated by M1 receptors (Hamilton et
al., 1997 ) but appears to involve both G q and
G 11 and also a pertussis toxin-sensitive G-protein (Haley et al., 2000 ). The suppression of
sIAHP by muscarinic agonists in CA1
neurons is instead linked to M3 receptor
activation (Rouse et al., 2000 ) and is mediated principally by
G q, in a similar way to that observed for the
M1-mediated inhibition of the N-type calcium
current in sympathetic neurons (Haley et al., 2000 ). The preponderant
involvement of G q in the
M3- and mGluR5-mediated suppression of sIAHP presented in this
study is in agreement with previous works using pharmacological
approaches to show that G-proteins, and in particular pertussis
toxin-insensitive ones, were essential components of the muscarinic and
mGluR signal cascades converging on
sIAHP (Dutar and Nicoll, 1988 ; Gerber
et al., 1992 ; Abdul-Ghani et al., 1996a ; Krause and Pedarzani,
2000 ).
Beside modulating sIAHP, muscarinic
and mGluR agonists induce a depolarization of the membrane potential in
CA1 neurons. The underlying current has been ascribed to the inhibition
of at least two types of K+ currents: the
voltage-dependent M current (Brown and Adams, 1980 ; Halliwell and
Adams, 1982 ; McCormick and Williamson, 1989 ) and a voltage-independent
leak current (Madison et al., 1987 ; Guerineau et al., 1994 ). More
recently, a cation nonselective current has been proposed to be mainly
responsible for the depolarization generated by muscarinic and mGluR
agonists in cortical and hippocampal neurons (Crepel et al., 1994 ;
Greene et al., 1994 ; Guerineau et al., 1995 ; Haj-Dahmane and Andrade,
1997 , 1999 ). Interestingly, mGluR1 receptors have
been shown recently to elicit an inward, depolarizing current
associated with a slow excitatory postsynaptic response in a
G-protein-independent manner in CA3 pyramidal neurons (Heuss et al.,
1999 ). Our experiments show that neither the lack of
G q nor G 11 affect the
depolarizing action of M3 muscarinic and
mGluR5 receptors in CA1 pyramidal neurons. Our
results are compatible with the possibility that muscarinic and mGluR
agonists induce a depolarization of the membrane potential in a
G-protein-independent manner in CA1 neurons, as proposed recently for
CA3 neurons (Heuss et al., 1999 ).
The signal transduction events downstream from M3
or mGluR5 and G-protein activation, leading to
sIAHP suppression,
IK(leak) inhibition, and activation of
a depolarizing cationic conductance, are still rather unclear.
Calcium/calmodulin-dependent kinase II has been shown to be involved in
the muscarinic, but not in the mGluR, modulation of
sIAHP (Müller et al., 1992 ;
Pedarzani and Storm, 1996 ), suggesting that the two receptors might be
coupled to distinct pathways. In dentate gyrus granule cells, PLC,
IP3, and a tyrosine kinase have been reported to
mediate the glutamatergic suppression of
sIAHP (Abdul-Ghani et al., 1996a ,b ),
whereas in CA1 pyramidal neurons neither PLC nor
IP3 seem to be involved in the inhibition of this
current by muscarinic or mGluR agonists (Krause and Pedarzani, 1999 ,
2000 ). Instead, we obtained evidence for the involvement of a protein
phosphatase (Krause and Pedarzani, 1999 , 2000 ), but the mechanism of
coupling to G-proteins needs to be elucidated. The present study
provides evidence that signaling of both M3
muscarinic and mGluR5 receptors converge onto the
same G-protein, G q, to modulate
sIAHP. Future experiments will show whether the residual effect on sIAHP
observed in G q-deficient mice is attributable
to the coupling of M3 and
mGluR5 to a parallel, second pathway, activated
by  subunits, by G-proteins not belonging to the
Gq family, or by a G-protein-independent mechanism.
 |
FOOTNOTES |
Received May 31, 2001; revised Oct. 9, 2001; accepted Nov. 6, 2001.
This work was supported by Deutsche Forschungsgemeinschaft
Sonderforschungsbereich 406 (M.S., P.P.), the Human
Frontier Science Program (P.P.), and the Wellcome Trust (M.S.). We are
very grateful to Walter Stühmer for generous support. We thank
David A. Brown for useful discussion and critical reading of this
manuscript and Christina Sterner and the personnel of the transgenic
animal facility of the Max-Planck-Institute for Experimental Medicine for technical assistance.
Correspondence should be addressed to Dr. Paola Pedarzani, Department
of Physiology, University College London, Gower Street, London WC1E
6BT, UK. E-mail: p.pedarzani{at}ucl.ac.uk.
M. Krause's present address: Pharmacia Corporation, Neurobiology, 301 Henrietta Street, Kalamazoo, MI 49007.
 |
REFERENCES |
-
Abdul-Ghani MA,
Valiante TA,
Carlen PL,
Pennefather PS
(1996a)
Metabotropic glutamate receptors coupled to IP3 production mediate inhibition of IAHP in rat dentate granule neurons.
J Neurophysiol
76:2691-2700[Abstract/Free Full Text].
-
Abdul-Ghani MA,
Valiante TA,
Carlen PL,
Pennefather PS
(1996b)
Tyrosine kinase inhibitors enhance a Ca2+-activated K+ current (IAHP) and reduce IAHP suppression by a metabotropic glutamate receptor agonist in rat dentate granule neurones.
J Physiol (Lond)
496:139-144[ISI].
-
Benardo LS,
Prince DA
(1982)
Cholinergic excitation of mammalian hippocampal pyramidal cells.
Brain Res
249:315-331[ISI][Medline].
-
Blanton MG,
Lo Turco JJ,
Kriegstein AR
(1989)
Whole cell recording from neurons in slices of reptilian and mammalian cerebral cortex.
J Neurosci Methods
30:203-210[ISI][Medline].
-
Brown DA,
Adams PR
(1980)
Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone.
Nature
283:673-676[Medline].
-
Brown DA,
Abogadie FC,
Allen TG,
Buckley NJ,
Caulfield MP,
Delmas P,
Haley JE,
Lamas JA,
Selyanko AA
(1997)
Muscarinic mechanisms in nerve cells.
Life Sci
60:1137-1144[ISI][Medline].
-
Buckley NJ,
Abogadie FC,
Brown DA,
Dayrell M,
Caulfield MP,
Delmas P,
Haley JE
(2000)
Use of antisense expression plasmids to attenuate G-protein expression in primary neurons.
Methods Enzymol
314:136-148[Medline].
-
Charpak S,
Gähwiler BH,
Do KQ,
Knöpfel T
(1990)
Potassium conductances in hippocampal neurons blocked by excitatory amino-acid transmitters.
Nature
347:765-767[Medline].
-
Cole AE,
Nicoll RA
(1983)
Acetylcholine mediates a slow synaptic potential in hippocampal pyramidal cells.
Science
221:1299-1301[Abstract/Free Full Text].
-
Cole AE,
Nicoll RA
(1984)
The pharmacology of cholinergic excitatory responses in hippocampal pyramidal cells.
Brain Res
305:283-290[ISI][Medline].
-
Colino A,
Halliwell JV
(1993)
Carbachol potentiates Q current and activates a calcium-dependent non-specific conductance in rat hippocampus in vitro.
Eur J Neurosci
5:1198-1209[ISI][Medline].
-
Crepel V,
Aniksztejn L,
Ben-Ari Y,
Hammond C
(1994)
Glutamate metabotropic receptors increase a Ca2+-activated nonspecific cationic current in CA1 hippocampal neurons.
J Neurophysiol
72:1561-1569[Abstract/Free Full Text].
-
Dutar P,
Nicoll RA
(1988)
Classification of muscarinic responses in hippocampus in terms of receptor subtypes and second-messenger systems: electrophysiological studies in vitro.
J Neurosci
8:4214-4224[Abstract].
-
Exton JH
(1996)
Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins.
Annu Rev Pharmacol Toxicol
36:481-509[ISI][Medline].
-
Gerber U,
Sim JA,
Gähwiler BH
(1992)
Reduction of potassium conductances mediated by metabotropic glutamate receptors in rat CA3 pyramidal cells does not require protein kinase C or protein kinase A.
Eur J Neurosci
4:792-797[ISI][Medline].
-
Gereau RW,
Conn PJ
(1995)
Roles of specific metabotropic glutamate receptor subtypes in regulation of hippocampal CA1 pyramidal cell excitability.
J Neurophysiol
74:122-129[Abstract/Free Full Text].
-
Greene CC,
Schwindt PC,
Crill WE
(1994)
Properties and ionic mechanisms of a metabotropic glutamate receptor-mediated slow afterdepolarization in neocortical neurons.
J Neurophysiol
72:693-704[Abstract/Free Full Text].
-
Greif GJ,
Sodickson DL,
Bean BP,
Neer EJ,
Mende U
(2000)
Altered regulation of potassium and calcium channels by GABAB and adenosine receptors in hippocampal neurons from mice lacking G
o.
J Neurophysiol
83:1010-1018[Abstract/Free Full Text]. -
Guerineau NC,
Gähwiler BH,
Gerber U
(1994)
Reduction of resting K+ current by metabotropic glutamate and muscarinic receptors in rat CA3 cells: mediation by G-proteins.
J Physiol (Lond)
474:27-33[Abstract/Free Full Text].
-
Guerineau NC,
Bossu JL,
Gähwiler BH,
Gerber U
(1995)
Activation of a nonselective cationic conductance by metabotropic glutamatergic and muscarinic agonists in CA3 pyramidal neurons of the rat hippocampus.
J Neurosci
15:4395-4407[Abstract].
-
Haj-Dahmane S,
Andrade R
(1997)
Calcium-activated cation nonselective current contributes to the fast afterdepolarization in rat prefrontal cortex neurons.
J Neurophysiol
78:1983-1989[Abstract/Free Full Text].
-
Haj-Dahmane S,
Andrade R
(1999)
Muscarinic receptors regulate two different calcium-dependent non-selective cation currents in rat prefrontal cortex.
Eur J Neurosci
11:1973-1980[ISI][Medline].
-
Haley JE,
Abogadie FC,
Delmas P,
Dayrell M,
Vallis Y,
Milligan G,
Caulfield MP,
Brown DA,
Buckley NJ
(1998)
The
subunit of Gq contributes to muscarinic inhibition of the M-type potassium current in sympathetic neurons.
J Neurosci
18:4521-4531[Abstract/Free Full Text]. -
Haley JE,
Delmas P,
Offermanns S,
Abogadie FC,
Simon MI,
Buckley NJ,
Brown DA
(2000)
Muscarinic inhibition of calcium current and M current in G
q-deficient mice.
J Neurosci
20:3973-3979[Abstract/Free Full Text]. -
Halliwell JV,
Adams PR
(1982)
Voltage-clamp analysis of muscarinic excitation in hippocampal neurons.
Brain Res
250:71-92[ISI][Medline].
-
Hamilton SE,
Loose MD,
Qi M,
Levey AI,
Hille B,
McKnight GS,
Odzerda RL,
Nathanson NM
(1997)
Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice.
Proc Natl Acad Sci USA
94:13311-13316[Abstract/Free Full Text].
-
Heuss C,
Scanziani M,
Gähwiler BH,
Gerber U
(1999)
G-protein-independent signaling mediated by metabotropic glutamate receptors.
Nat Neurosci
2:1070-1077[ISI][Medline].
-
Hille B
(1994)
Modulation of ion-channel function by G-protein-coupled receptors.
Trends Neurosci
17:531-536[ISI][Medline].
-
Holscher C,
Gigg J,
O'Mara SM
(1999)
Metabotropic glutamate receptor activation and blockade: their role in long-term potentiation, learning and neurotoxicity.
Neurosci Biobehav Rev
23:399-410[ISI][Medline].
-
Ikeda SR
(1997)
Heterologous expression of receptors and signaling proteins in adult mammalian sympathetic neurons by microinjection.
Methods Mol Biol
83:191-202[Medline].
-
Kleppisch T,
Allmann R,
Voigt V,
Offermanns S
(2001)
G
q-deficient mice lack mGluR-dependent LTD but show normal LTP in the hippocampal CA1 region.
J Neurosci
21:4943-4948[Abstract/Free Full Text]. -
Krause M,
Pedarzani P
(1999)
Suppression of the Ca2+-activated K+ current sIAHP by cholinergic and glutamatergic agonists involves a protein phosphatase and PKG in hippocampal neurons.
In: Proceedings of the 1st Göttingen Conference of the German Neuroscience Society, p 702 Stuttgart: Verlag.
-
Krause M,
Pedarzani P
(2000)
A protein phosphatase is involved in the cholinergic suppression of the Ca2+-activated K+ current sIAHP in hippocampal pyramidal neurons.
Neuropharmacology
39:1274-1283[ISI][Medline].
-
Lei Q,
Talley EM,
Bayliss DA
(2001)
Receptor-mediated inhibition of G protein-coupled inwardly rectifying potassium channels involves G
q family subunits, phospholipase C, and a readily diffusible messenger.
J Biol Chem
276:16720-16730[Abstract/Free Full Text]. -
Madison DV,
Lancaster B,
Nicoll RA
(1987)
Voltage-clamp analysis of cholinergic action in the hippocampus.
J Neurosci
7:733-741[Abstract].
-
Mailleux P,
Mitchell F,
Vanderhaeghen JJ,
Milligan G,
Erneux C
(1992)
Immunohistochemical distribution of neurons containing the G-proteins Gq alpha/G11 alpha in the adult rat brain.
Neuroscience
51:311-316[ISI][Medline].
-
McCormick DA,
von Krosigk M
(1992)
Corticothalamic activation modulates thalamic firing through glutamate metabotropic receptors.
Proc Natl Acad Sci USA
89:2774-2778[Abstract/Free Full Text].
-
McCormick DA,
Williamson A
(1989)
Convergence and divergence of neurotransmitter action in human cerebral cortex.
Proc Natl Acad Sci USA
86:8098-8102[Abstract/Free Full Text].
-
McFadzean I,
Caulfield MP,
Vallis Y,
Brown DA
(1994)
Injection of antisera into cells to study G-protein regulation of channel function.
Methods Enzymol
238:357-364[Medline].
-
|